Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8759318
APP PUB NO 20120052046A1
SERIAL NO

13143098

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Phosphoramidate compounds derived from guanine bases having enhanced therapeutic potency are provided, and these compounds in particular have enhanced potency with respect to treatment of viral infections, such as hepatitis C virus. Pharmaceutical compositions, methods of preparing the compounds, and methods of using the compounds and compositions to treat viral infections are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INHIBITEX INC1165 SANCTUARY PARKWAY SUITE 400 ALPHARETTA GA 30004

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aljarah, Mohamed Cardiff, GB 1 84
Chamberlain, Stanley Alpharetta, US 5 139
Gilles, Arnaud Cardiff, GB 1 84
Hutchins, Jeff Alpharetta, US 5 119
Madela, Karolina Cardiff, GB 4 118
McGuigan, Christopher Cardiff, GB 46 1233
Vernachio, John Alpharetta, US 10 203

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 24, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00